Harry Lam

Dr. Lam is Executive Vice President of Technical Operations at JW Therapeutics. Previously, he was Head of Therapeutic Technical Operations at 23andMe, Vice President and Head of Manufacturing at Sanofi and Shire Regenerative Medicine. Prior to Sanofi and Shire, he worked in various leadership roles in CMC and manufacturing engineering at Genentech-Roche. Dr. Lam received his B.S. in Chemical Engineering from the University of Birmingham, and his Ph.D. in Chemical Engineering from Rensselaer Polytechnic Institute.